GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Prolight Diagnostics AB (NGM:PRLD) » Definitions » ROE % Adjusted to Book Value

Prolight Diagnostics AB (NGM:PRLD) ROE % Adjusted to Book Value : 9.10% (As of Dec. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Prolight Diagnostics AB ROE % Adjusted to Book Value?

Prolight Diagnostics AB's ROE % for the quarter that ended in Dec. 2024 was 6.64%. Prolight Diagnostics AB's PB Ratio for the quarter that ended in Dec. 2024 was 0.73. Prolight Diagnostics AB's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was 9.10%.


Prolight Diagnostics AB ROE % Adjusted to Book Value Historical Data

The historical data trend for Prolight Diagnostics AB's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prolight Diagnostics AB ROE % Adjusted to Book Value Chart

Prolight Diagnostics AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only -1.45 -4.40 - -101.34 -28.25

Prolight Diagnostics AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -355.44 -37.01 -48.55 -33.09 9.10

Competitive Comparison of Prolight Diagnostics AB's ROE % Adjusted to Book Value

For the Medical Instruments & Supplies subindustry, Prolight Diagnostics AB's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Prolight Diagnostics AB's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Prolight Diagnostics AB's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Prolight Diagnostics AB's ROE % Adjusted to Book Value falls into.


;
;

Prolight Diagnostics AB ROE % Adjusted to Book Value Calculation

Prolight Diagnostics AB's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-20.62% / 0.73
=-28.25%

Prolight Diagnostics AB's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=6.64% / 0.73
=9.10%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Prolight Diagnostics AB ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Prolight Diagnostics AB's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Prolight Diagnostics AB Business Description

Traded in Other Exchanges
N/A
Address
Gasverksgatan 3A, Lund, SWE, 222 29
Prolight Diagnostics AB along with its subsidiaries, develops Point-of-Care (POC) systems, which are small, portable instruments and disposable cartridges for performing in-vitro diagnostic (IVD) tests from a drop of blood. Its product portfolio includes Psyros, a digital POC technology, and Microflex.